Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Small cell lung cancer

J A Hinson1, M C Perry

  • 1Division of Pulmonary Care and Environmental Medicine, University of Missouri School of Medicine, Columbia.

CA: a Cancer Journal for Clinicians
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility.

Scientific reports·2020
Same author

Haemoglobin adducts as biomarkers of exposure to the herbicides propanil and fluometuron.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2013
Same author

Differential effect of age on survival in advanced NSCLC in women versus men: analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumab.

Lung cancer (Amsterdam, Netherlands)·2012
Same author

Gemcitabine and pemetrexed administered in rapid sequence as front-line chemotherapy for advanced non-small-cell lung cancer: a phase II clinical trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2009
Same author

Acetaminophen-associated hepatic injury: evaluation of acetaminophen protein adducts in children and adolescents with acetaminophen overdose.

Clinical pharmacology and therapeutics·2008
Same author

Number of repetitions to maximum in hop tests in patients with anterior cruciate ligament injury.

International journal of sports medicine·2005
Same journal

Extranodal natural killer/T-cell lymphoma: From fatal to curable.

CA: a cancer journal for clinicians·2026
Same journal

Data support longer recurrence-free survival with nivolumab than with ipilimumab for stage III or IV melanoma.

CA: a cancer journal for clinicians·2026
Same journal

Study finds ovarian cancer survivors who are BRCA carriers have a relatively low risk of breast cancer.

CA: a cancer journal for clinicians·2026
Same journal

Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma.

CA: a cancer journal for clinicians·2026
Same journal

Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates.

CA: a cancer journal for clinicians·2026
Same journal

Correction to "Integrating multimodal management and molecular profiling in a patient with BRAF V600E-positive melanoma and brain metastases".

CA: a cancer journal for clinicians·2026
See all related articles

Small cell lung cancer (SCLC) is an aggressive lung cancer with rapid spread and poor survival. This review covers its epidemiology, pathology, and treatment options.

Area of Science:

  • Oncology
  • Pulmonology
  • Medical Research

Background:

  • Small cell lung cancer (SCLC) represents approximately 25% of all lung cancer diagnoses.
  • SCLC is distinguished by its aggressive nature, characterized by rapid tumor growth and early metastasis.
  • Untreated SCLC has the shortest survival rate among all lung neoplasms, with a median survival of 2-4 months.

Purpose of the Study:

  • To provide a comprehensive overview of small cell lung cancer.
  • To consolidate current knowledge on SCLC epidemiology, pathology, and clinical presentation.
  • To detail the established staging and treatment modalities for SCLC.

Main Methods:

  • Literature review of epidemiological data.
  • Pathological analysis of SCLC characteristics.

Related Experiment Videos

  • Clinical case study review for characteristics and staging.
  • Analysis of treatment outcomes for radiotherapy and chemotherapy.

    • Main Results:

    • SCLC exhibits rapid growth and dissemination at the time of diagnosis.
    • The disease shows significant responsiveness to both radiotherapy and chemotherapy.
    • Median survival for untreated SCLC is critically short, ranging from two to four months.

    Conclusions:

    • SCLC is a distinct and aggressive form of lung cancer requiring specific management strategies.
    • Early diagnosis and prompt treatment are crucial for improving outcomes in SCLC patients.
    • Further research into novel therapeutic approaches for SCLC remains essential.